Getting molnupiravir to patients in a timely way is likely to be problematic
BMJ
.
2021 Nov 2:375:n2648.
doi: 10.1136/bmj.n2648.
Author
Peter M B English
1
Affiliation
1
Epsom, UK.
PMID:
34728494
DOI:
10.1136/bmj.n2648
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents* / therapeutic use
COVID-19*
Humans
Substances
Antiviral Agents